Mira Dx Launches Ovarian Cancer Risk Test
Mira Dx Launches Ovarian Cancer Risk Test
Genomics startup Mira Dx announced this week that it has launched a new test designed to identify women at increased risk of developing ovarian cancer based on a genetic variant that affects a key microRNA.
Read more on GenomeWeb News